These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Pharmacokinetics of nitrosoureas: comparison of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) after oral and intravenous administration to rats. Russo RG, Cattaneo MT, Bartosek I. Tumori; 1984 Dec 31; 70(6):499-502. PubMed ID: 6531792 [Abstract] [Full Text] [Related]
6. Relationship of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) pharmacokinetics of uptake, distribution, and tissue/plasma partitioning in rat organs and intracerebral tumors. Levin VA, Kabra PA, Freeman-Dove MA. Cancer Chemother Pharmacol; 1978 Dec 31; 1(4):233-42. PubMed ID: 750110 [Abstract] [Full Text] [Related]
7. Pharmacokinetics of nitrosoureas: levels of 1,3-bis-(2-chloroethyl)-1-nitrosourea (BCNU) in organs of normal and Walker 256/B carcinoma bearing rats after i.v. bolus. Bartosek I, Russo RG, Cattaneo MT. Tumori; 1984 Dec 31; 70(6):491-8. PubMed ID: 6531791 [Abstract] [Full Text] [Related]
8. Microsomal metabolism of nitrosoureas. Hill DL, Kirk MC, Struck RF. Cancer Res; 1975 Feb 31; 35(2):296-301. PubMed ID: 234031 [Abstract] [Full Text] [Related]
9. Pharmacokinetics of intracarotid artery 14C-BCNU in the squirrel monkey. Levin VA, Kabra PM, Freeman-Dove MA. J Neurosurg; 1978 Apr 31; 48(4):587-93. PubMed ID: 416182 [Abstract] [Full Text] [Related]
10. Stimulation of ultraviolet-induced carcinogenesis by 1,3-Bis(2-chloroethyl)-1-nitrosourea. Epstein JH. Cancer Res; 1979 Feb 31; 39(2 Pt 1):408-10. PubMed ID: 761213 [Abstract] [Full Text] [Related]
11. Pharmacokinetics of the antineoplastic agent 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in the aqueous and vitreous of rabbit. Ueno N, Refojo MF, Liu LH. Invest Ophthalmol Vis Sci; 1982 Aug 31; 23(2):199-208. PubMed ID: 7096015 [Abstract] [Full Text] [Related]
12. Pronounced damage of intestinal tract mucosa by the combination of 1-methyl-1-nitrosourea plus 1,3-bis-(2-chloroethyl)-1-nitrosourea. Effect of drug sequence and time interval of administration. Zeller WJ, Komitowski D. Toxicol Lett; 1986 Aug 31; 32(1-2):59-64. PubMed ID: 3526639 [Abstract] [Full Text] [Related]
14. Analysis and distribution of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in biological specimens. Hochberg FH, Poletti CE, Krull IS, Strauss J. Neurosurgery; 1983 Sep 31; 13(3):230-3. PubMed ID: 6621835 [Abstract] [Full Text] [Related]
15. Glutathione-dependent denitrosation of N,N'-bis(2-chloroethyl)N-nitrosourea (BCNU): nitrite release catalyzed by mouse liver cytosol in vitro. Talcott RE, Levin VA. Drug Metab Dispos; 1983 Sep 31; 11(2):175-6. PubMed ID: 6133726 [No Abstract] [Full Text] [Related]
17. Pharmacokinetics of positron-labeled 1,3-bis(2-chloroethyl)nitrosourea in human brain tumors using positron emission tomography. Diksic M, Sako K, Feindel W, Kato A, Yamamoto YL, Farrokhzad S, Thompson C. Cancer Res; 1984 Jul 31; 44(7):3120-4. PubMed ID: 6609769 [Abstract] [Full Text] [Related]
18. Role of O6-alkylguanine-DNA alkyltransferase in protecting against 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU)-induced long-term toxicities. Hansen RJ, Nagasubramanian R, Delaney SM, Cherian MM, Lin S, Kogan SC, Dolan ME. J Pharmacol Exp Ther; 2005 Dec 31; 315(3):1247-55. PubMed ID: 16126841 [Abstract] [Full Text] [Related]